LENSARvsMerck & Company

LNSR and MRK stock compared: price, dividend, valuation and results, from SEC filings.

LNSR

LENSAR, Inc.

$4.64

Value $56M

-4.33%
LNSR's page

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.61%
MRK's page

LENSAR (LNSR) has a market value of $56M and Merck & Company (MRK) $328B. Over the last year, with dividends, LNSR moved -53.5% and MRK +41.8%. Dividend yield: LNSR none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LNSR$56M

    MRK$328B

    MRK is 5,846 times LNSR

  • Revenue, 12 months

    LNSR$60M

    MRK$67.4B

    MRK is 1,121 times LNSR

  • Net income, 12 months

    LNSR$34M

    MRK$2.5B

    MRK is 73 times LNSR

  • Operating margin

    LNSR-3.3%

    MRK–

  • ROIC

    LNSR–

    MRK3.9%

  • P/E

    LNSR–

    MRK133.9

  • Dividend yield

    LNSR0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    LNSR-34.7%

    MRK+86.3%

    121.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LNSR-34.7%

MRK+86.3%

10020020222023202420252026
Returns by period
PeriodLNSRWith dividendsMRKWith dividends
1 year since November 18, 2025-53.5%Price -53.5%+41.8%Price +37.7%
3 years since November 17, 2023+111.9%+28.4% a yearPrice +111.9%+43.1%+12.7% a yearPrice +30.5%
5 years since November 18, 2021-34.7%-8.2% a yearPrice -34.7%+86.3%+13.2% a yearPrice +59.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LNSRLENSARMRKMerck & Company

Valuation

LNSRMRK
Valuation
Price$4.64$132.81
Market value$56M$328B
Enterprise value (EV)$45M$372B
P/E–133.9
P/E, 5-year median–14.8
P/B5.17.3
EV/EBIT–78.2
Free cash flow yield–4.5%

Results and growth

LNSRMRK
Results and growth
Revenue, 12 months$60M$67.4B
Net income, 12 months$34M$2.5B
Free cash flow, 12 months-$4.8M$14.7B
Earnings per share, 12 months-$0.40$0.98
Revenue growth, year on year9.2%1.3%
Revenue growth a year, past+17.2%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

LNSRMRK
Margins and returns on capital
Gross margin52.0%71.8%
Operating margin-3.3%–
Net margin56.1%3.6%
ROIC–3.9%
ROE–5.2%

Balance sheet

LNSRMRK
Balance sheet
Cash$13M$9.7B
Total debt$4.1M$53.8B
Net debt / EBITDA-6.75.7
Interest cover–2.4×

Dividends and buybacks

LNSRMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LNSR or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, LENSAR or Merck & Company?

By market value, Merck & Company ($328B) is about 5,846.4 times LENSAR ($56M), at today's prices.

How did LNSR and MRK stock do over the last 5 years?

Since November 18, 2021, LNSR's price moved -34.7% and MRK's +59.9%. With dividends: LNSR -34.7% (-8.2% a year), MRK +86.3% (+13.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, LNSR or MRK?

The dividend yield at today's price is none for LENSAR and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, LENSAR or Merck & Company?

Over the last twelve months, the net margin was 56.1% for LENSAR and 3.6% for Merck & Company, and the operating margin -3.3% and –. Revenue was $60M and $67.4B.

Which is the better investment, LENSAR or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.